Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed 
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions 
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks 
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos 
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom 
Want to cut your energy bills? Here’s how five experts are doing it 
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
ALLEN, Texas, Feb. 23, 2017 -- Atrion Corporation (NASDAQ:ATRI) today announced that its Board of Directors declared a quarterly dividend of $1.05 per share on its outstanding shares of Common Stock. This dividend will be payable on March 31, 2017 to stockholders of record at the close of business on March 15, 2017.
Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com.
Contact: Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800
